What’s new at CHBRP? FEATURED Jul 5, 2023 Status of 2023 Bills Analyzed by CHBRP As bills move through the Legislature, bills may be significantly amended, which may alter CHBRP’s projected impacts. CHBRP maintains a record of the extent to which CHBRP’s analyses remain relevant as the bills move through the Legislative process. Jul 5, 2023 Status of 2023 Bills Analyzed by CHBRP Jun 9, 2023 CHBRP has completed its analysis of SB 635 (Menjivar and Portantino): Hearing Aids May 16, 2023 CHBRP has received a request to analyze SB 839 (Bradford): Obesity Treatment Parity Act May 11, 2023 CHBRP has received a request from the Legislature to prepare a report centered on the ways in which California-regulated healthcare service plans and health insurers are utilizing prior authorization. Apr 24, 2023 CHBRP has completed its analysis of AB 1060 (Ortega): Naloxone Hydrochloride Apr 24, 2023 CHBRP has completed its analysis of AB 1048 (Wicks): Dental Benefits and Rate Review Apr 24, 2023 CHBRP has completed its analysis of SB 427 (Portantino): Antiretroviral Drugs, Devices, and Products Apr 24, 2023 CHBRP has completed its analysis of SB 339 (Wiener): HIV Preexposure Prophylaxis and Postexposure Prophylaxis Apr 24, 2023 CHBRP has completed its analysis of AB 907 (Lowenthal): Coverage for PANDAS and PANS. Apr 24, 2023 CHBRP has completed its analysis of AB 1451 (Jackson): Behavioral Health Crisis Treatment Apr 24, 2023 CHBRP has completed its analysis of AB 874 (Weber): Out-of-pocket Expenses Apr 24, 2023 CHBRP has completed its analysis of SB 729 (Menjivar): Treatment for Infertility and Fertility Services Apr 18, 2023 CHBRP has completed its analysis of SB 1645 (Zbur): Cost Sharing Apr 18, 2023 CHBRP has completed its analysis of AB 1157 (Ortega): Rehabilitative and Habilitative Services: Durable Medical Equipment and Services Apr 18, 2023 CHBRP has completed its analysis of SB 694 (Eggman): Medi-Cal: Self-Measured Blood Pressure Devices and Services Apr 18, 2023 CHBRP has completed its analysis of AB 1288 (Reyes): Medication-Assisted Treatment Apr 18, 2023 CHBRP has completed its analysis of SB 621 (Connolly): Metabolic Disorders Apr 18, 2023 CHBRP has completed its analysis of AB 716 (Boerner Horvath): Emergency Ground Medical Transportation Apr 18, 2023 CHBRP has completed its analysis of SB 621 (Caballero): Biosimilar Drugs Mar 21, 2023 CHBRP has completed its analysis of SB 90 (Wiener): Insulin Affordability Mar 21, 2023 CHBRP has completed its analysis of SB 70 (Wiener): Prescription Drug Coverage Pagination Current page 1 Page 2 Next page Next Last page Last
